V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002628 | 240007224 | 1.73 | 72.2 | Curative (C) | null | 2022-02-03 | ALL UKALL2011 Cap Int Maint C PAsp | N | null | R CODOX-M/ R IVAC | 100453163 |
| 240002637 | 240007229 | 1.74 | 72.6 | null | 2018-01-12 | 2018-01-12 | null | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100056675 |
| 240002641 | 240007231 | 1.61 | 112 | Disease modification (D) | 2019-06-20 | 2019-08-01 | R GDP | N | N | BENDAMUSTINE | 101158486 |
| 240002643 | 240007232 | 0 | 79.2 | Palliative (P) | 2019-02-03 | 2019-02-03 | ALL Interim Guide 2019 Maintenance | 01 | N | ANAGRELIDE | 100655920 |
| 240002644 | 240007233 | 1.65 | 98 | Palliative (P) | 2017-09-14 | 2017-09-28 | R-GDP | 02 | null | CARBOPLATIN + VINCRISTINE | 100290839 |
| 240002647 | 240007234 | 1.85 | 12.8 | 03 | 2017-02-14 | 2017-02-19 | FCR Oral - Cycle 2 onwards | 02 | N | BENDAMUSTINE | 101189509 |
| 240002652 | 240007238 | 1.78 | 80 | 03 | 2018-05-02 | 2018-05-02 | null | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100611346 |
| 240002654 | 240007240 | 1.62 | 25 | Curative (C) | 2018-07-10 | 2018-07-10 | null | 02 | null | CISPLATIN + GEMCITABINE | 100976932 |
| 240002657 | 240007242 | 1.58 | 74.4 | Palliative (P) | 2019-09-30 | 2019-10-01 | BUSULFAN | 02 | null | CYCLOPHOSPHAMIDE | 100373006 |
| 240002660 | 240007244 | 1.85 | 83.3 | 03 | null | 2018-06-11 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | Y | N | RUXOLITINIB | 101569313 |
| 240002661 | 240007245 | 0 | 51.6 | Curative (C) | 2019-09-18 | 2019-09-20 | R IVAC | 02 | N | CYTARABINE + DAUNORUBICIN | 100392129 |
| 240002662 | 240007246 | null | null | Curative (C) | 2018-05-12 | 2019-05-20 | AML MyeChild 01 IT Cyt | 02 | N | RUXOLITINIB | 100465389 |
| 240002665 | 240007247 | 1.81 | 119.2 | Curative (C) | 2016-03-26 | 2016-03-28 | RCEOP | 02 | N | RUXOLITINIB | 101355122 |
| 240002667 | 240007248 | 1.67 | 74.35 | 03 | 2018-06-13 | 2018-06-29 | TRANSPLANT BEAM | 01 | N | ALL UKALL2011 DEL INT C | 100169468 |
| 240002668 | 240007249 | 1.75 | 58.5 | null | 2016-05-22 | 2016-06-01 | null | 01 | null | ALL UKALL2011 CAP INT MAINT C | 101535543 |
| 240002669 | 240007250 | 1.73 | 88.8 | Curative (C) | 2018-01-16 | 2018-02-17 | DA | 02 | null | INTERFERON ALFA | 100856222 |
| 240002670 | 240007251 | 1.8 | 15.35 | Curative (C) | 2018-03-26 | 2018-04-04 | GDP | 02 | N | RUXOLITINIB | 100949403 |
| 240002677 | 240007254 | 1.65 | 9.95 | null | 2018-02-28 | 2018-03-14 | null | 02 | null | IMATINIB | 101757779 |
| 240002680 | 240007255 | 1.62 | 78 | null | 2018-07-25 | 2018-07-26 | IMATINIB | 02 | null | ALL ALLR3: MAINT | 100497751 |
| 240002681 | 240007256 | 1.62 | 77 | Curative (C) | 2017-03-10 | 2017-03-17 | BEAM | null | N | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101392613 |
| 240002682 | 240007257 | 1.86 | 90 | null | 2019-09-20 | 2019-09-20 | DA-EPOCH-R | Y | null | DABRAFENIB | 101240251 |
| 240002685 | 240007258 | 1.43 | 25.05 | Palliative (P) | null | 2019-08-22 | null | null | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100765527 |
| 240002686 | 240007259 | 1.83 | 82.3 | Curative (C) | 2021-07-26 | 2021-07-26 | GDP | 02 | null | QUIZARTINIB | 100504024 |
| 240002687 | 240007260 | 0 | 82 | Curative (C) | 2020-02-17 | 2020-02-24 | null | 02 | null | ALL UKALL2011 STD BFM CONS B | 101805483 |
| 240002688 | 240007261 | 1.58 | 78 | Curative (C) | 2018-09-19 | 2019-02-09 | ALL Interim Guide 2019 Capizzi Interim Maintenance C | null | N | RUXOLITINIB | 100782832 |
| 240002689 | 240007262 | 1.78 | 66 | Curative (C) | null | 2019-05-09 | null | 02 | N | DABRAFENIB | 101438199 |
| 240002690 | 240007263 | 1.69 | 95.4 | null | null | 2020-03-19 | AML MyeChild 01 FLA-Idarubicin | null | null | METHOTREXATE INTRATHECAL | 100728299 |
| 240002691 | 240007264 | 1.65 | 76.1 | Palliative (P) | 2018-03-11 | 2018-04-02 | null | 01 | null | IDELALISIB + RITUXIMAB | 101090800 |
| 240002692 | 240007265 | 1.75 | 64 | Curative (C) | 2017-06-11 | 2017-06-18 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | null | METHOTREXATE + PEGASPARAGINASE | 101690729 |
| 240002694 | 240007266 | 1.65 | 121.4 | Curative (C) | 2019-11-13 | 2019-11-22 | null | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100890404 |
| 240002695 | 240007267 | 0 | 73.5 | null | 2019-08-29 | 2019-08-29 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | IMATINIB | 100491904 |
| 240002697 | 240007268 | 1.71 | 45.1 | Curative (C) | 2018-04-18 | 2018-04-18 | CARBOPLATIN + VINCRISTINE | 01 | null | AML DOWNS AIE | 100451551 |
| 240002698 | 240007269 | 1.73 | 54.9 | null | 2018-12-01 | 2018-12-02 | FLAG + Idarubicin | 02 | null | CYTARABINE + DAUNORUBICIN | 100763372 |
| 240002702 | 240007270 | 1.65 | 58.65 | null | null | 2019-09-13 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | null | null | ALL UKALL2011 IND A | 101607922 |
| 240002703 | 240007271 | 1.79 | 70.8 | Curative (C) | 2019-09-28 | 2019-11-09 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100907534 |
| 240002704 | 240007272 | 1.77 | 54.6 | null | 2019-02-18 | 2019-03-06 | R IVAC | null | null | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 101247286 |
| 240002708 | 240007274 | 0 | 44 | null | 2020-11-30 | 2020-11-30 | Ixazomib + Lenalidomide | 02 | null | RUXOLITINIB | 100556069 |
| 240002710 | 240007275 | 1.8 | 30.45 | Curative (C) | null | 2019-10-24 | AML Relapsed FLA | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE | 100363568 |
| 240002711 | 240007276 | 1.7 | 89.2 | Not known (9) | 2016-08-15 | 2016-09-28 | FLAG + Idarubicin | Y | null | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100108939 |
| 240002715 | 240007277 | 1.84 | 77.1 | Curative (C) | 2017-09-27 | 2017-11-08 | ANAGRELIDE | Y | N | RUXOLITINIB | 100309500 |
| 240002716 | 240007278 | 1.5 | 68.7 | Curative (C) | 2020-05-24 | 2020-08-04 | Triple Intrathecal | 02 | null | VINBLASTINE | 100664609 |
| 240002717 | 240007279 | 1.8 | 52.2 | Palliative (P) | 2016-11-25 | 2016-11-26 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | RUXOLITINIB | 100375542 |
| 240002719 | 240007280 | 1.73 | 91.6 | Curative (C) | 2018-03-03 | 2018-03-09 | AML MyeChild 01 A Mitozantrone/Cytarabine | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101330307 |
| 240002720 | 240007281 | 1.6 | 17.3 | Curative (C) | 2018-12-05 | 2018-12-05 | Etoposide PBSCT Mobilisat (1.6g/m2) | 02 | null | DA | 100130048 |
| 240002722 | 240007282 | 0 | 0 | Palliative (P) | 2018-02-20 | 2018-02-20 | MUK 9 TRIAL | 02 | null | VENETOCLAX | 100415407 |
| 240002724 | 240007284 | 1.79 | 95.2 | Curative (C) | 2017-01-01 | 2017-02-18 | GEMTUZUMAB OZOGAMICIN | 02 | null | FLUDARABINE + THIOTEPA + TREOSULFAN | 101660295 |
| 240002727 | 240007286 | 0 | 34.9 | 03 | 2018-12-03 | 2018-12-03 | Cyclophosphamide+Fludara+TBI Allo | 01 | N | AML INTERIM GUIDELINES FLAG-IDA | 101854468 |
| 240002729 | 240007287 | 1.66 | 16.65 | Curative (C) | null | 2020-05-01 | null | N | N | CVP R | 101464129 |
| 240002730 | 240007288 | 1.59 | 81.5 | null | 2020-06-14 | 2020-06-15 | ALCL ALCL 99 Closed AM 1, 2 or 3 | Y | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100332081 |
| 240002733 | 240007290 | 1.79 | 76 | null | 2018-08-16 | 2018-09-12 | AML Interim Guidelines FLAG-Ida | 02 | null | AML INTERIM GUIDELINES FLAG-IDA | 101528355 |